Business Description
Thermo Fisher Scientific Inc
NAICS : 541380
SIC : 3826
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 3.14 | |||||
Interest Coverage | 5.1 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.4 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11 | |||||
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | 3.3 | |||||
3-Year FCF Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | 11.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 6.63 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.47 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.8 | |||||
9-Day RSI | 51.49 | |||||
14-Day RSI | 50.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.7 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 77.97 | |||||
Days Sales Outstanding | 69.51 | |||||
Days Payable | 40.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.07 | |||||
3-Year Dividend Growth Rate | 16.7 | |||||
Forward Dividend Yield % | 0.14 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | 0.4 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.63 | |||||
Operating Margin % | 17.26 | |||||
Net Margin % | 14.2 | |||||
FCF Margin % | 17.79 | |||||
ROE % | 13.49 | |||||
ROA % | 6.26 | |||||
ROIC % | 7.94 | |||||
ROC (Joel Greenblatt) % | 52.41 | |||||
ROCE % | 9.72 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 36.78 | |||||
Forward PE Ratio | 26.75 | |||||
PE Ratio without NRI | 28.61 | |||||
Shiller PE Ratio | 47.22 | |||||
Price-to-Owner-Earnings | 32.38 | |||||
PEG Ratio | 1.88 | |||||
PS Ratio | 5.22 | |||||
PB Ratio | 4.81 | |||||
Price-to-Free-Cash-Flow | 29.39 | |||||
Price-to-Operating-Cash-Flow | 24.88 | |||||
EV-to-EBIT | 30.85 | |||||
EV-to-Forward-EBIT | 25.71 | |||||
EV-to-EBITDA | 21.65 | |||||
EV-to-Forward-EBITDA | 22.99 | |||||
EV-to-Revenue | 5.78 | |||||
EV-to-Forward-Revenue | 5.78 | |||||
EV-to-FCF | 32.88 | |||||
Price-to-Projected-FCF | 1.8 | |||||
Price-to-DCF (Earnings Based) | 0.03 | |||||
Price-to-DCF (FCF Based) | 0.03 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.02 | |||||
Earnings Yield (Greenblatt) % | 3.24 | |||||
FCF Yield % | 3.48 | |||||
Forward Rate of Return (Yacktman) % | 16.85 |